Attenuation of chronic mild stress-induced ‘anhedonia’ by asenapine is not associated with a ‘hedonic’ profile in intracranial self-stimulation
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Chronic mild stress (CMS)-induced ‘anhedonia’ is a predictive model of antidepressant activity. We assessed the reversal of CMS-induced behavioral changes by asenapine, the antidepressant imipramine, and the atypical antipsychotics olanzapine and risperidone. Secondarily, the ability of these agents to facilitate intracranial self-stimulation (ICSS) was assessed to ensure that any attenuation of CMS-induced anhedonia was not associated with an overt hedonic profile. After 2 weeks of CMS, male Wistar rats were administered asenapine (0.06–0.6 mg/kg), olanzapine (2 mg/kg), risperidone (0.5 mg/kg), or imipramine (10 mg/kg) by intraperitoneal injection over 5 weeks to examine their ability to reverse CMS-induced reductions in the intake of a sucrose solution. For the ICSS study, rats were trained to deliver an electrical stimulus to the ventral tegmental area. The effects of acute doses of subcutaneous asenapine (0.01–0.3 mg/kg), olanzapine (0.3 and 1 mg/kg), risperidone (0.1 and 0.3 mg/kg), and intraperitoneal imipramine (3–30 mg/kg), cocaine (5.0 mg/kg), or amphetamine (1.0 mg/kg) on ICSS were then examined. CMS significantly reduced sucrose intake ( P < 0.001). All active agents (0.6 mg/kg asenapine, 2 mg/kg olanzapine, 0.5 mg/kg risperidone, and 10 mg/kg imipramine) reversed the effect of CMS (all P < 0.001). In the ICSS protocol, asenapine (0.01 and 0.03 mg/kg), olanzapine (1 mg/kg), and risperidone (0.3 mg/kg) impaired ICSS performance, whereas positive controls (5 mg/kg cocaine, 1 mg/kg amphetamine) facilitated ICSS. Asenapine reversed CMS-induced anhedonia without facilitating ICSS, providing support for a role of asenapine in treating bipolar disorder and aspects of negative and/or affective symptoms in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832 · cited 2×
“Finally, it should be observed that the rightward shift state can be reversed with chronic treatment by the antidepressant desipramine (Moreau et al., 1992; Nielsen et al., 2000; Willner, 1997).”
BackgroundWillner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 1×
“However, a review by Willner (2005) indicated that the reliable decreases in daily sucrose intake, combined with supportive reports of CMSinduced ‘anhedonia’ in other animal models, suggest that this sucrose intake is a reliable index in this model.”
BackgroundAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“In this way, ICSS has been used to show that ‘anhedonic states’ induced by several preclinical models of depression are associated with a rightward shift of the rate-frequency function (Cryan et al., 2002; Slattery et al., 2007).”
MethodGriebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471 · cited 1×
“…using place preference (Muscat et al., 1992), maintenance coat condition (Mineur et al., 2006), plus maze, social avoidance and forced-swim tests (Griebel et al., 2002 a,b; Kompagne et al., 2008), sleep architecture (Cheeta et al., 1997) and intracranial self-stimulation (ICSS) paradigms…”
MethodEffects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice
Mineur, Y. S., Belzung, C., & Crusio, W. E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.029 · Cited by 459
Kodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387 · cited 2×
“Imipramine, risperidone, and olanzapine dose selection, as well as their routes of administration, were chosen based on previous reports (Kodama et al., 2004; Papp et al., 1996; Wakade et al., 2002).”
MethodResultBekris, S., Antoniou, K., Daskas, S., & Papadopoulou-Daifoti, Z. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.01.005 · Cited by 281
Pharmacological validation of the chronic mild stress model of depression
Papp, M., Moryl, E., & Willner, P. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00697-4 · Cited by 205
Self-citationDopaminergic mechanism of antidepressant action in depressed patients
Willner, P., Hale, A. S., & Argyropoulos, S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.010 · Cited by 169 · cited 1×
“However, even in the clinical study, the mixed D2/D3 antagonist sulpiride ‘slightly improved subjective well being in the [non-SSRI treated] control group’ (Willner et al., 2005).”
BackgroundPapp, M., Willner, P., & Muscat, R. (1993) · Psychopharmacology · doi:10.1007/bf02246966 · Cited by 47 · cited 3×
“…al., 1992), maintenance coat condition (Mineur et al., 2006), plus maze, social avoidance and forced-swim tests (Griebel et al., 2002 a,b; Kompagne et al., 2008), sleep architecture (Cheeta et al., 1997) and intracranial self-stimulation (ICSS) paradigms (Nielsen et al., 2000; Papp et al., 1993).”
BackgroundSelf-citation
Cited by
Antoniuk, S., Bijata, M., Ponimaskin, E., & Wlodarczyk, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.002 · Cited by 750
Mutlu, O., Gumuslu, E., Ulak, G., Celikyurt, I. K., Kokturk, S., Kır, H. M., Akar, F., & Erden, F. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.09.023 · Cited by 97
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
de Sousa, R. T., V. Zanetti, M., R. Brunoni, A., & Machado-Vieira, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630173522 · Cited by 43
“Also, asenapine is a new antipsychotic that showed to be effective in treating bipolar depression [57] and animal models [58]; studies in treatment-resistant MDD are warranted.”
BackgroundPapp, M., Gruca, P., Lason-Tyburkiewicz, M., Litwa, E., Niemczyk, M., Tota-Glowczyk, K., & Willner, P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4651-4 · Cited by 40
Metadata
- Authors
- Marston, H. M., Martin, F. D., Papp, M., Gold, L., Wong, E. H., & Shahid, M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-08-10
- Volume
- 25
- Issue
- 10
- Pages
- 1388-1398
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1974112189
- Cited by
- 27
- References
- 10
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attenuation of chronic mild stress-induced ‘anhedonia’ by asenapine is not associated with a ‘hedonic’ profile in intracranial self-stimulation. https://app.cochat.ai/papers/10.1177/0269881110376684
- The paper
- Marston, H. M., Martin, F. D., Papp, M., Gold, L., Wong, E. H., & Shahid, M. (2011). Attenuation of chronic mild stress-induced ‘anhedonia’ by asenapine is not associated with a ‘hedonic’ profile in intracranial self-stimulation. Journal of Psychopharmacology. https://doi.org/10.1177/0269881110376684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.